Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04606771
Title A Study Comparing Savolitinib Plus Osimertinib vs Savolitinib Plus Placebo in Patients With EGFRm+ and MET Amplified Advanced NSCLC (CoC)
Acronym CoC
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ARG

Facility Status City State Zip Country Details
Research Site Duarte California 91010 United States Details
Research Site Sacramento California 95817 United States Details
Research Site Buenos Aires C1120AAT Argentina Details
Research Site Delhi 110085 India Details
Research Site Mumbai 400053 India Details
Research Site Taichung City 402 Taiwan Details
Research Site Taipei 100 Taiwan Details
Research Site Taipei 11217 Taiwan Details
Research Site Taipei 235 Taiwan Details
Research Site Taoyuan City 333 Taiwan Details
Research Site Bangkok 10210 Thailand Details
Research Site Bangkok 10300 Thailand Details
Research Site Bangkok 10330 Thailand Details
Research Site Bangkok 10400 Thailand Details
Research Site Bangkok 10700 Thailand Details
Research Site Hat Yai 90110 Thailand Details
Research Site Khon Kaen 40002 Thailand Details
Research Site Muang 50200 Thailand Details
Research Site Ha Noi 100000 Vietnam Details
Research Site Hanoi 100000 Vietnam Details
Research Site Ho Chi Minh city 700000 Vietnam Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field